GRP and neoplasm: More recently the Smith group at the University of Missouri [28] designed and characterized new 64Cu-labeled bombesin targeting vector for molecular imaging studies in GRP-expressing tumor models and demonstrated high in vivo affinity and selectivity in prostate PC-3 tumor-bearing mouse model.